Stage
Acquired Unit | AcquiredValuation
$0000About SalvaRx Group - Immuno-Oncology Assets
The SalvaRx Group is a drug discovery and development company focused on immune-oncology; SalvaRx invests in novel cancer immuno-therapies and provides its portfolio companies with operational support ranging from direct operation of subsidiaries to advisory or part-time involvement in more established companies.
SalvaRx Group - Immuno-Oncology Assets Frequently Asked Questions (FAQ)
Where is SalvaRx Group - Immuno-Oncology Assets's headquarters?
SalvaRx Group - Immuno-Oncology Assets's headquarters is located at Commerce House, 1 Bowring Road, Isle of Man.
What is SalvaRx Group - Immuno-Oncology Assets's latest funding round?
SalvaRx Group - Immuno-Oncology Assets's latest funding round is Acquired Unit.
Who are the investors of SalvaRx Group - Immuno-Oncology Assets?
Investors of SalvaRx Group - Immuno-Oncology Assets include Portage Biotech.